Advice on the electronic submission of procedural documents
The BVL strives to simplify the national and European marketing authorisation procedures for veterinary medicinal products as well as the post-marketing procedures.
The English website on Veterinary medicines is under construction. Please refer to the German website in case desired information cannot be found here.
An overview
Electronic submission of documents for applications (eSubmission)
Since As of 28th of January 2022, the BVL only accepts electronic submissions of documents for marketing authorisation and registration procedures for veterinary medicinal products, as well as their follow-up procedures.
Electronic submission of product literature
According to the "Guideline on eSubmissions for Veterinary Products", all application documents must be submitted electronically.
Electronic submission of adverse event reports following the use of veterinary medicinal products
Adverse event reports must be submitted electronically to the European Medicines Agency (EMA).
Further information
Find out more
- General information
- Advice on the electronic submission of procedural documents
- Approval of clinical trials according to §10 TAMG
- Notification form for veterinary medicinal product shortages
- Regulatory flexibility in the context of the COVID-19 pandemic
- Brexit
- Forms for various procedures in the veterinary field
- Costs
- Pharmacovigilance obligations and pharmacovigilance information for pharmaceutical companies
- Further information on veterinary medicinal products
- Register of online veterinary medicinal products retailers